Internal Medicine · Fountain Valley, CA
NPI
1619110830
Since 2009
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
11180 Warner Ave, Suite 157
Fountain Valley, CA, 92708
Phone (714) 825-0891
Groups this clinician bills Medicare through
Medicare paid, 2024
$487K
62,099 services
Medicare patients, 2024
264
Average age 75
Drug cost, 2024
$2.7M
2,213 prescriptions
Company payments, 2025
$2,117
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eric Panahi was code J3262 (injection, tocilizumab, 1 mg), 49,520 times for 18 patients. In total Eric Panahi billed 62,099 services in 30 codes, and Medicare paid $487K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-05-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 49,520 | 18 | $4.72 | $234K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 9,400 | 20 | $9.14 | $86K |
| 99214 Office E&M - Established | Office | 675 | 232 | $95.90 | $65K |
| 96401 Chemotherapy Administration | Office | 544 | 61 | $59.70 | $32K |
| J9260 Injection, methotrexate sodium, 50 mg | Office | 499 | 44 | $2.05 | $1,022 |
| 96413 Chemotherapy Administration | Office | 271 | 77 | $110.63 | $30K |
| 97032 PT Treatment | Office | 130 | 24 | $9.10 | $1,183 |
| 97112 PT Treatment | Office | 130 | 24 | $23.56 | $3,062 |
| 20610 Joint Injection | Office | 67 | 33 | $54.59 | $3,657 |
| 99204 Office E&M - New | Office | 48 | 48 | $126.16 | $6,056 |
| J7321 Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 44 | 15 | $53.47 | $2,353 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 41 | 34 | $0.68 | $27.91 |
| 93922 Duplex Scan - Extremity Arteries | Office | 32 | 32 | $71.08 | $2,274 |
| 95921 Electrical Nerve Conductivity | Office | 31 | 31 | $64.12 | $1,988 |
| 95923 Electrical Nerve Conductivity | Office | 30 | 30 | $103.30 | $3,099 |
By year: 2022 $332K for 28,314 services; 2023 $517K for 61,312 services; 2024 $487K for 62,099 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 17 | 15 | $2.97 | $50.46 |
Medicare prescription drug claims, 2024
In 2024, the drug Eric Panahi prescribed most often to Medicare patients was Actemra (Tocilizumab), with 220 prescriptions and refills. In total Eric Panahi wrote 2,213 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Actemra Tocilizumab | 220 | 223 | 22 | $540K |
| Methotrexate Methotrexate Sodium | 94 | 259 | 45 | $2,794 |
| Hydroxychloroquine Sulfate Generic | 81 | 212 | 37 | $3,409 |
| Simponi Aria Golimumab | 81 | 136 | 21 | $536K |
| Gabapentin Generic | 65 | 184 | 26 | $1,276 |
| Duloxetine Hcl Generic | 63 | 172 | 35 | $1,448 |
| Prednisone Generic | 61 | 120 | 24 | $405 |
| Sodium Chloride 0.9 % Sodium Chloride | 51 | 58 | 17 | $98.13 |
| Amlodipine Besylate Generic | 49 | 136 | 20 | $292 |
| Famotidine Generic | 46 | 137 | 21 | $524 |
| Tymlos Abaloparatide | 44 | 49 | Under 11 | $124K |
| Omeprazole Generic | 41 | 119 | 17 | $667 |
| Pregabalin Generic | 39 | 95 | 17 | $1,562 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 35 | 38 | 15 | $577 |
| Lisinopril Generic | 32 | 94 | 13 | $365 |
Brand drugs: - claims; generic drugs: 1,569 claims; opioid claims: 76.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eric Panahi $2,117 ($2,117 in general payments such as food, travel and fees) from 16 companies. The largest payer was Amgen Inc. with $417.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 30 | $417 |
| UCB, Inc. UCB.BR | 16 | $318 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $270 |
| Mallinckrodt Hospital Products Inc. | 13 | $264 |
| Abbvie Inc. ABBV | 9 | $214 |
| Pfizer Inc. PFE | 6 | $131 |
| GlaxoSmithKline, LLC. GSK | 4 | $103 |
| Lilly USA, LLC LLY | 4 | $96.24 |
| Radius Health, Inc. | 4 | $89.79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $59.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.